Drug
Revexepride clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses revexepride is read from its arms, and is right about nine times in ten.
Testing it · 3
- SSP-002358 Drug Interaction Study With OmeprazoleCompletedPhase 1ShireNCT01415349Written as SSP-002358
- An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD PatientsTerminatedPhase 2ShireNCT01370863Written as SPD557
- Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)CompletedPhase 2ShireNCT01472939Written as SSP-002358 (0.1 mg) + PPI
Codes
What other systems call revexepride · ClinicalTrials.gg INT000288
- MeSH (NLM) C000600233revexeprideOne source NLM
- UNII (FDA) 8C63R2Y02MREVEXEPRIDEConfirmed FDA, NLM, Wikidata
- Wikidata Q27270174revexeprideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152202RevexeprideOne source FDA
- DrugBank DB20324One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000600233 | revexepride | One source NLM |
| UNII (FDA) | 8C63R2Y02M | REVEXEPRIDE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27270174 | revexepride | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152202 | Revexepride | One source FDA |
| DrugBank | DB20324 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.